Latest News about MRK
Recent news which mentions MRK
The 20 worst U.S. stocks in February: the biggest loser dropped 36%
February 28, 2023
From MarketWatch
Analyst Cautions Investors On Overreacting To 'Early-Stage' Pfizer/Seagen Discussions
February 27, 2023
From Benzinga
Seagen Stock Soars On Pfizer Takeover Talks: What's Going On?
February 27, 2023
From Benzinga
From MarketWatch
Pfizer In Early Talks To Buy Cancer-Focused Seagen: WSJ
February 26, 2023
From Benzinga
US Senators Warren, Sanders Urge 'Close Scrutiny' On Merck's Keytruda-Related Patents
February 24, 2023
Tickers
MRK
From Benzinga
WHO panel is reviewing whether COVID vaccines need updating, as agency monitors 7 omicron subvariants
February 24, 2023
From MarketWatch
European Authority Recommends Against Approval For Merck-Ridgeback Biotherapeutics' COVID-19 Pill
February 24, 2023
Tickers
MRK
From Benzinga
Moderna’s stock slides as earnings fall short of estimates amid steep decline in COVID-vaccine sales
February 23, 2023
From MarketWatch
From Benzinga
Intel’s dividend cut shows the need for quality. Here are 20 dividend stocks screened by UBS.
February 22, 2023
From MarketWatch
Benzinga's Top Ratings Upgrades, Downgrades For February 22, 2023
February 22, 2023
From Benzinga
This Recession-Proof Company Has a Best-in-Class Dividend
February 22, 2023
From Motley Fool
Jim Cramer Lists 6 Conditions For Market Selloff To End Amid 'Discouraging' Inflation Data
February 21, 2023
From Benzinga
3 Large-Cap Biotech Stocks to Hold for the Long Haul
February 19, 2023
From InvestorPlace
I ‘Tricked’ ChatGPT Into Picking Stocks to Buy. Here’s What It Said.
February 17, 2023
From InvestorPlace
Should Income Investors Buy This Dow Jones Stock?
February 17, 2023
From Motley Fool
Why Shares of Organon Fell 15% Thursday
February 16, 2023
From Motley Fool
Merck Says Keytruda/Chemo Combo Improved Overall Survival Compared To Chemo Alone In Gastric Cancer Settings
February 16, 2023
Tickers
MRK
From Benzinga
2 Ultra-Safe Dividend Stocks to Buy Right Now
February 16, 2023
From Motley Fool
2 Market-Beating Dividend Stocks to Buy With $500
February 16, 2023
From Motley Fool
EXCLUSIVE: How To Lower The Cost Of Cannabis Quality And Save 30% Of Your Top-Line Revenue
February 15, 2023
From Benzinga
Robinhood, Merck And 2 Other Stocks Insiders Are Selling
February 15, 2023
From Benzinga
Why Top Ships Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 14, 2023
From Benzinga
BioXcel Therapeutics Unveils Complete Data From BXCL701/Keytruda Combo Study In Prostate Cancer Subtype
February 14, 2023
From Benzinga
Acurx is Setting a High Bar for New Treatments in C. diff
February 14, 2023
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.